SEC Filings
Press Releases
February 5, 2009 Health Discovery Corporation Licenses Biomarkers for Noninvasive Urine-Based Prostate Cancer Test to Quest Diagnostics
February 5, 2009 Health Discovery Corporation Licenses New Prostate Cancer Test to Abbott
January 13, 2009 Clarient Launches Gene Expression Test for Prostate Cancer
November 6, 2008 Health Discovery Corporation: Four Genes Comprising The New Molecular Diagnostic Signature for Prostate Cancer Successfully Identified in Urine
October 8, 2008 Health Discovery Corporation's New Prostate Cancer Test is Ready for Commercialization Following Successful Completion of Final Clinical Trials
August 12, 2008 Health Discovery Corporation's Newest US Patent Covers SVM-Based Analysis of Medical Images
August 11, 2008 New Prostate Cancer Test to be Presented at Biomarker Discovery Europe 2008 Conference
August 7, 2008 New Prostate Cancer Test is Ready for Commercialization Following Successful Completion of Final Clinical Trials
August 4, 2008 Health Discovery Corporation Inks Agreement with Patent Profit International for Monetization of Patent Portfolio
July 24, 2008 New Computer Assisted Diagnostic Tests for Ovarian Cancer, Cervical Cancer and Endometrial Cancer to be Jointly Developed by Health Discovery Corporation and DCL Medical Laboratories
June 24, 2008 Health Discovery Corporation Announces Successful Phase II Clinical Trial Results for New Gene-Based Molecular Diagnostic Test for Prostate Cancer
May 8, 2008 Health Discovery Corporation Announces the Issuance of Two New US Patents Covering Applications of Support Vector Machines (SVM's)
May 6, 2008 Health Discovery Corporation and DCL Medical Laboratories to Develop a Computer Assisted Diagnostic Test for Cervical Cancer
April 30, 2008 Health Discovery Corporation Announces Successful Clinical Trial Results for New Molecular Diagnostic Test for Prostate Cancer
